In the past few years, health experts have warned that popular diabetes drugs like Byetta may be linked to increased risks of pancreatic and thyroid cancer. Now, with the growing number of patients coming forward to file injury claims, questions are arising over how to handle the litigation.
A 2011 study from UCLA indicated Byetta could be linked to a 290% higher occurrence of pancreatic cancer and a 473% higher rate of thyroid cancer. This year, the Journal for the American Medical Association and Institute for Safe Medication Practices have both warned that drugs like Byetta can increase pancreatitis and pancreatic cancer risks.
With millions of patients using diabetes medications Byetta, Januvia and Janumet, experts believe thousands could be affected. So far, nearly 60 claims have been filed around the country.
Last month, lawyers asked that diabetes drug cancer cases be consolidated to a special federal multi-district court in California. Now, a response from Byetta maker Merck shows the manufacturer agrees with the plan.
A federal multi-district litigation court system could give victims the advantage of a class action lawsuit without losing control over their individual cases. Similar litigation has been used for Yaz, Actos and Pradaxa injury claims.
Pancreatic cancer is a severe condition. Anyone affected by this or thyroid cancer after taking Byetta should speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled diabetes drug cancer lawsuits.
Contact us today for more information on the research, side effects and litigation news related to Byetta, or to speak with a lawyer.